Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.140
+0.040 (1.29%)
At close: May 27, 2026, 4:00 PM EDT
3.100
-0.040 (-1.27%)
After-hours: May 27, 2026, 7:45 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $25.09 million as of May 27, 2026. Its market cap has increased by 120.13% in one year.

Market Cap
25.09M
Enterprise Value
18.04M
1-Year Change
120.13%
Ranking
#4931
Category
Nano-Cap
Stock Price
$3.14

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $25.09M, an increase of 234.59%. That is a compound annual growth rate of 6.05%.

History

DateMarket Cap% Change
May 26, 202624.80M98.40%
Dec 31, 202512.50M1.63%
Dec 31, 202412.30M-63.82%
Dec 29, 202334.00M112.50%
Dec 30, 202216.00M-60.59%
Dec 31, 202140.60M-27.24%
Dec 31, 202055.80M164.45%
Dec 31, 201921.10M185.14%
Dec 31, 20187.40M-65.90%
Dec 29, 201721.70M233.85%
Dec 30, 20166.50M3.17%
Dec 31, 20156.30M-73.08%
Dec 31, 201423.40M9.86%
Dec 31, 201321.30M-37.72%
Dec 31, 201234.20M187.39%
Dec 30, 201111.90M325.00%
Dec 31, 20102.80M-98.80%
Dec 31, 2009233.20M2,164.08%
Dec 31, 200810.30M-56.90%
Dec 31, 200723.90M-22.90%
Dec 29, 200631.00M-30.49%
Dec 30, 200544.60M494.67%
Nov 10, 20057.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Dyadic International27.66M
Allarity Therapeutics27.37M
Tempest Therapeutics26.68M
Palatin Technologies25.70M
Vistagen Therapeutics25.63M
Jasper Therapeutics25.28M
BriaCell Therapeutics25.13M
Celularity25.09M
Market Cap Rankings